Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-07-20

Clinical Trial Update: Non-Invasive Brain Stimulation for Medication-Resistant Auditory Hallucinations in Schizophrenia Patients [NA]

View source ↗

Summary

The trial evaluating non-invasive brain stimulation for medication-resistant auditory hallucinations in schizophrenia has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Minnesota | Conditions: Auditory Hallucinations, Schizophrenia | NA | Status: WITHDRAWN